Silverfleet Plans To Sell Sterigenics

(Reuters) – Private equity firm Silverfleet Capital is seeking to sell Sterigenics, the Chicago-based firm whose gamma-ray sterilisation technology is used by medical device makers, sources familiar with the situation said on Thursday.

Silverfleet is hoping the business, which it bought in 2004, will fetch about $800 million and expects it will attract interest from private equity firms and trade bidders, the sources said.

Silverfleet declined comment. Sterigenics’s listed competitors include Steris Corp (STE.N) and Canada’s MDS Nordion (MDS.TO).